A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma
Status:
Completed
Trial end date:
2020-11-18
Target enrollment:
Participant gender:
Summary
This is a study to determine the safety and effectiveness of high-dose radiation therapy (RT)
with concurrent temozolomide in patients with newly diagnosed glioblastoma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center